Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q5308921> ?p ?o }
Showing triples 1 to 46 of
46
with 100 triples per page.
- Q5308921 subject Q7056690.
- Q5308921 subject Q7300121.
- Q5308921 abstract "Drug repositioning (also known as drug repurposing, re-profiling, re-tasking or therapeutic switching) is the application of known drugs and compounds to new indications (i.e., new diseases).A significant advantage of drug repositioning over traditional drug development is that since the repositioned drug has already passed a significant number of toxicity and other tests, its safety is known and the risk of failure for reasons of adverse toxicology are reduced. More than 90% of drugs fail during development, and this is the most significant reason for the high costs of pharmaceutical R&D. In addition, repurposed drugs can bypass much of the early cost and time needed to bring a drug to market. On the other hand drug repositioning faces some challenges itself since the intellectual property issues surrounding the original drug may be complex and from a commercial point of view it may not always make sense to take such a drug to market.Drug repositioning has been growing in importance in the last few years as an increasing number of drug development and pharmaceutical companies see their drug pipelines drying up and realize that many previously promising technologies have failed to deliver ‘as advertised’. Computational approaches based on virtual screening of comprehensive libraries of approved and other human use compounds against large numbers of protein targets simultaneously have been developed to enhance the efficiency and success rates of drug repositioning, particularly in terms of high-throughput shotgun repurposing.".
- Q5308921 wikiPageExternalLink www.cureswithinreach.org.
- Q5308921 wikiPageExternalLink www.fda.gov.
- Q5308921 wikiPageExternalLink S1359644614002530.
- Q5308921 wikiPageWikiLink Q11173.
- Q5308921 wikiPageWikiLink Q1151300.
- Q5308921 wikiPageWikiLink Q12136.
- Q5308921 wikiPageWikiLink Q12140.
- Q5308921 wikiPageWikiLink Q1225158.
- Q5308921 wikiPageWikiLink Q14873747.
- Q5308921 wikiPageWikiLink Q14874282.
- Q5308921 wikiPageWikiLink Q154430.
- Q5308921 wikiPageWikiLink Q184674.
- Q5308921 wikiPageWikiLink Q191521.
- Q5308921 wikiPageWikiLink Q203174.
- Q5308921 wikiPageWikiLink Q206921.
- Q5308921 wikiPageWikiLink Q2198549.
- Q5308921 wikiPageWikiLink Q2325854.
- Q5308921 wikiPageWikiLink Q274160.
- Q5308921 wikiPageWikiLink Q303646.
- Q5308921 wikiPageWikiLink Q3774474.
- Q5308921 wikiPageWikiLink Q407535.
- Q5308921 wikiPageWikiLink Q407541.
- Q5308921 wikiPageWikiLink Q407721.
- Q5308921 wikiPageWikiLink Q410352.
- Q5308921 wikiPageWikiLink Q412174.
- Q5308921 wikiPageWikiLink Q416827.
- Q5308921 wikiPageWikiLink Q420590.
- Q5308921 wikiPageWikiLink Q427523.
- Q5308921 wikiPageWikiLink Q47270.
- Q5308921 wikiPageWikiLink Q4915389.
- Q5308921 wikiPageWikiLink Q507443.
- Q5308921 wikiPageWikiLink Q5514847.
- Q5308921 wikiPageWikiLink Q60168.
- Q5308921 wikiPageWikiLink Q6812559.
- Q5308921 wikiPageWikiLink Q7056690.
- Q5308921 wikiPageWikiLink Q7300121.
- Q5308921 wikiPageWikiLink Q81225.
- Q5308921 wikiPageWikiLink Q842947.
- Q5308921 wikiPageWikiLink Q899036.
- Q5308921 wikiPageWikiLink Q899107.
- Q5308921 wikiPageWikiLink Q905835.
- Q5308921 comment "Drug repositioning (also known as drug repurposing, re-profiling, re-tasking or therapeutic switching) is the application of known drugs and compounds to new indications (i.e., new diseases).A significant advantage of drug repositioning over traditional drug development is that since the repositioned drug has already passed a significant number of toxicity and other tests, its safety is known and the risk of failure for reasons of adverse toxicology are reduced.".
- Q5308921 label "Drug repositioning".